Related Experiment Video
Updated: May 22, 2026

13:42
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
Recent advances in the biosensing platforms for sepsis diagnosis
Vishwesh Dutt Mishra1,2, Mohit Pandey1,3, Hemant Kumar1,2
1Microsystem Fabrication Lab, Indian Institute of Technology Kanpur Kanpur U.P. India bhattacs@iitk.ac.in.
RSC Advances
|May 21, 2026
Summary
Sepsis is a leading cause of death, necessitating rapid detection. This study reviews sepsis biosensors, focusing on sensitivity, limit of detection, and novel mechanisms for early infection diagnosis.
Area of Science:
- Biomedical Engineering
- Infectious Disease Diagnostics
- Sensor Technology
Background:
- Sepsis causes significant global mortality and organ damage, highlighting the urgent need for timely diagnosis and treatment.
- Existing pathogen detection methods vary in sensitivity and limit of detection (LOD), with challenges in blood biomarker extraction and preservation.
- Resource-limited settings require accessible, low-energy diagnostic tools, such as paper-based or microfluidic devices.
Purpose of the Study:
- To comprehensively review recent advancements and challenges in sepsis-related biosensors.
- To discuss various biosensor categories, biomarkers, LODs, and sensing mechanisms for sepsis detection.
- To explore the impact of artificial intelligence and machine learning on sepsis diagnostics.
Main Methods:
- Review of current literature on sepsis biosensors, encompassing neonatal sepsis.
- Analysis of six categories of sepsis biosensors, detailing biomarkers, LODs, and sensing mechanisms.
- Discussion of challenges in blood biomarker detection and preservation.
Main Results:
- Sepsis biosensors offer diverse sensing mechanisms, impacting reliability and durability.
- Key performance metrics include sensitivity and limit of detection (LOD), crucial for early diagnosis.
- Emerging AI and machine learning techniques are enhancing diagnostic processes for sepsis.
Conclusions:
- Advancements in biosensor technology are crucial for improving sepsis detection rates and patient outcomes.
- Optimizing sensing mechanisms and addressing biomarker challenges are vital for developing robust sepsis diagnostic tools.
- Integrating AI and machine learning holds promise for innovative and efficient sepsis diagnosis.
Related Concept Videos
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...